Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Dr. Amir Qamar, MD

Gastroenterology Burlington, MA Male

NPI: 1629054820

Total Payments

$10,845

2020 Payments

$1,019

Companies

Transactions

Medicare Patients

1,295

Medicare Billing

$194,359

Payment Breakdown by Category

Consulting$10,750 (99.1%)

Food & Beverage$94.77 (0.9%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Consulting Fee	$10,750	11	99.1%
Food and Beverage	$94.77	2	0.9%

Top Paying Companies

Company	Total	Records	Latest Year
Merck Sharp & Dohme Corporation	$10,750	11	$0 (2020)
Abbott Laboratories	$75.88	1	$0 (2018)
Veloxis Pharmaceuticals, Inc.	$18.89	1	$0 (2020)

Payment History by Year

Year	Amount	Transactions	Top Company
2020	$1,019	2	Merck Sharp & Dohme Corporation ($1,000)
2019	$4,000	4	Merck Sharp & Dohme Corporation ($4,000)
2018	$4,076	5	Merck Sharp & Dohme Corporation ($4,000)
2017	$1,750	2	Merck Sharp & Dohme Corporation ($1,750)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date	Company	Product	Nature	Form	Amount	Type
01/21/2020	Veloxis Pharmaceuticals, Inc.	Envarsus (Drug)	Food and Beverage	Cash or cash equivalent	$18.89	General
Category: Immunosuppressant
01/08/2020	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
12/04/2019	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
08/28/2019	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
06/05/2019	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
02/28/2019	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
11/15/2018	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
08/09/2018	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
05/23/2018	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
04/15/2018	Abbott Laboratories	Asahi Fielder coronary guide wire (Device), Hi-Torque coronary guide wire, NC TREK coronary catheters	Food and Beverage	In-kind items and services	$75.88	General
Category: Vascular
02/14/2018	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
11/01/2017	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: ENDOCRINOLOGY
07/26/2017	Merck Sharp & Dohme Corporation	STEGLATRO (Drug)	Consulting Fee	Cash or cash equivalent	$750.00	General
Category: ENDOCRINOLOGY

Medicare Billing by Year

Year	Procedures	Beneficiaries	Services	Submitted	Medicare Paid
2023	9	334	528	$199,249	$48,126
2022	8	317	495	$166,366	$44,254
2021	8	288	587	$187,541	$52,189
2020	8	356	639	$172,472	$49,789

Total Patients

1,295

Total Services

2,249

Medicare Billing

$194,359

Procedure Codes

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS	Description	Setting	Year	Patients	Services	Charges	Medicare Paid	Ratio
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2023	155	232	$79,885	$17,753	22.2%
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	Facility	2023	30	107	$33,675	$10,887	32.3%
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2023	57	78	$38,056	$9,392	24.7%
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	Facility	2023	19	20	$11,840	$3,006	25.4%
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	Facility	2023	22	40	$8,802	$2,693	30.6%
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	Facility	2023	16	16	$6,410	$1,803	28.1%
99204	New patient office or other outpatient visit, 45-59 minutes	Facility	2023	13	13	$6,394	$1,386	21.7%
45380	Biopsy of large bowel using a flexible endoscope	Facility	2023	11	11	$13,095	$1,155	8.8%
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	Facility	2023	11	11	$1,092	$52.89	4.8%
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2022	146	224	$71,220	$17,666	24.8%
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2022	54	84	$37,100	$10,159	27.4%
99233	Follow-up hospital inpatient care per day, typically 35 minutes	Facility	2022	26	74	$22,151	$6,598	29.8%
99223	Initial hospital inpatient care per day, typically 70 minutes	Facility	2022	23	26	$15,076	$4,482	29.7%
99232	Follow-up hospital inpatient care per day, typically 25 minutes	Facility	2022	18	30	$6,312	$1,863	29.5%
99443	Telephone medical discussion with physician, 21-30 minutes	Facility	2022	20	26	$5,443	$1,781	32.7%
99205	New patient office or other outpatient visit, 60-74 minutes	Facility	2022	11	11	$6,552	$1,620	24.7%
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	Facility	2022	19	20	$2,512	$84.59	3.4%
99214	Established patient outpatient visit, total time 30-39 minutes	Facility	2021	128	262	$80,580	$20,656	25.6%
99233	Subsequent hospital inpatient care, typically 35 minutes per day	Facility	2021	32	149	$43,529	$12,989	29.8%
99215	Established patient outpatient visit, total time 40-54 minutes	Facility	2021	38	59	$25,244	$7,264	28.8%
99223	Initial hospital inpatient care, typically 70 minutes per day	Facility	2021	20	21	$11,786	$3,696	31.4%
99443	Physician telephone patient service, 21-30 minutes of medical discussion	Facility	2021	29	37	$7,458	$2,552	34.2%
99232	Subsequent hospital inpatient care, typically 25 minutes per day	Facility	2021	15	33	$6,687	$2,084	31.2%
99222	Initial hospital inpatient care, typically 50 minutes per day	Facility	2021	15	15	$5,679	$1,792	31.5%
43235	Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope	Facility	2021	11	11	$6,578	$1,156	17.6%

1 2 »

About Dr. Amir Qamar, MD

Dr. Amir Qamar, MD is a Gastroenterology healthcare provider based in Burlington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629054820.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Qamar, MD has received a total of $10,845 in payments from pharmaceutical and medical device companies, with $1,019 received in 2020. These payments were reported across 13 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($10,750).

As a Medicare-enrolled provider, Qamar has provided services to 1,295 Medicare beneficiaries, totaling 2,249 services with total Medicare billing of $194,359. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Gastroenterology
Other Specialties Hepatology
Location Burlington, MA
Active Since 12/20/2005
Last Updated 10/16/2017
Taxonomy Code 207RG0100X
Entity Type Individual
NPI Number 1629054820

Products in Payments

STEGLATRO (Drug) $10,750
Asahi Fielder coronary guide wire (Device) $75.88
Envarsus (Drug) $18.89

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.